chartexchange

CAPR
Capricor Therapeutics Inc
stockNASDAQ

Market OpenNov 19, 2026 3:33:45 PM EST
7.61USD-5.293%(-0.42)6,346,943
Pre-marketNov 19, 2026 9:29:30 AM EST
8.18USD+1.868%(+0.15)
7.6000Bid7.6400Ask0.0400Spread
Loading…
Loading…
441.59M
Healthcare
Biotechnology
CEO
Linda Marban
HQ
San Diego, CA, USA
Previous Close
$8.03
Beta
0.18
52-Week High
$40.37 2025-12-03
52-Week Low
$2.96 2026-07-30
SMA 50
$8.05
SMA 200
$19.82
Avg. Vol 10D
5.42M
Avg. Vol 30D
3.75M
Avg. Vol 90D
6.08M
Relative Vol
1.62
52.66M
18,765,089
1.8000%
8,926
Jun 5, 2019 · 1-for-10 (reverse)
CAPR Profile

capricor therapeutics, inc. (nasdaq: capr) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. our innovative technology builds upon a large body of scientific research and enables us to approach the treatment of diseases in novel ways. capricor's lead candidate, cap-1002, is an "off-the-shelf" cardiac cell therapy that is currently in clinical development for the treatment of duchenne muscular dystrophy (dmd). cap-1002 consists of allogeneic cardiosphere-derived cells, or cdcs, a unique population of cells which include progenitor cells that have been shown to exert potent immunomodulatory activity, which alters the immune system's activity to stimulate cellular regeneration. cdcs have been the subject of over 100 peer-reviewed scientific publications and have been administered to approximately 140 human subjects across several clinical trials. capricor has

CAPR Performance
PeriodPriceDateChangeBeta
1W10.242026-11-12-25.83%3.888
1M6.652026-10-19+14.21%3.036
3M7.982026-08-19-4.83%2.601
6M26.922026-05-19-71.79%0.616
1Y5.772025-11-19+31.63%0.177
2Y18.462024-11-19-58.86%—
5Y3.332021-11-19+128.42%-0.232
CAPR Stock Summary

Capricor Therapeutics Inc (NASDAQ:CAPR) stock price today is $7.60, and today's volume is 6,094,701. CAPR is down 5.417% today. The 30 day average volume is 3.75M. CAPR market cap is $441.59M with 58.14M shares outstanding.